InnovAge Holding Corp. (INNV) fair value analysis
Nasdaq · Updated 2026-09-07
InnovAge Holding Corp. is a healthcare company that provides integrated care services to Medicare Advantage members, including primary care, behavioral health, pharmacy, and other medical services. The company operates through senior care centers and community-based programs primarily in the western United States.
Valuation status
Awaiting full valuationINNV does not yet have sufficient validated earnings history for a full Forward Fair Value verdict under our standards — we require at least six validated trailing price-to-earnings windows before publishing one. TickrTrends re-evaluates every covered stock weekly; a verdict publishes automatically once enough validated history accumulates.
- Last price
- $11.23
- Sector
- Healthcare
- 12-month range
- $4.74–$11.71
Derived indicators
Coarse bands from TickrTrends' weekly models; exact figures are part of the full report.
- Quality grade
- D
- Leverage
- Low
- RSI zone
- Neutral
- 50/200-day trend
- Uptrend
- 52-week position
- The top quarter of its range
What our data shows for INNV
- Our model validated 4 trailing price-to-earnings windows for INNV, built from quarterly earnings records.
- Shares are trading in the upper third of their 12-month price range of $4.74–$11.71.
- The 14-day relative strength index sits at a neutral 44.
The exact numbers are one step away
- The precise Forward Fair Value dollar figure for INNV
- Exact discount / premium to today's price
- The normalized historical P/E behind the estimate, and how many quarters support it
- Forward EPS input and fiscal-year basis
- Screeners and rankings across the full S&P 500 and Nasdaq universes
How Forward Fair Value works
TickrTrends computes a Forward Fair Value for every covered stock each week: a conservatively normalized historical price-to-earnings multiple is applied to the analyst-consensus earnings estimate for the next full fiscal year. Every input window is validated for continuity and every result is screened for plausibility before publication.
Recent INNV news
TickrTrends' derived news-sentiment signal for INNV is currently mixed, computed from recent coverage.
- Biotech Movers: Modular Medical Jumps, InnovAge Revenue Up 16%, Pyxis Data On Deck, Dogwood In Focus (rttnews.com, 2026-09-09)
TickrTrends take: InnovAge Holding Corp. reported revenue growth of 16%, which provides concrete operational performance data relevant to assessing its valuation foundations in the Healthcare sector. With TickrTrends currently awaiting a full valuation determination for INNV, investors monitoring this stock should track whether this revenue expansion translates into improvements in profitability metrics and cash flow that would support valuation multiples. The timing of this revenue report offers an opportunity for analysts to incorporate updated financial performance into a comprehensive valuation framework. - InnovAge Holding Corp. (INNV) Q4 2026 Earnings Call Transcript (seekingalpha.com, 2026-09-09)
TickrTrends take: InnovAge's Q4 2026 earnings call provides the financial detail necessary for TickrTrends to complete its valuation assessment of the Healthcare company. Investors monitoring INNV should focus on revenue trends, operating margins, and cash flow metrics disclosed during the earnings discussion, as these factors will inform whether the company warrants a positive, neutral, or cautious valuation verdict. The transition from awaiting full valuation to a defined verdict depends on whether management's reported results and forward guidance support the company's current market positioning within the Healthcare sector. - InnovAge Holding Corp. (INNV) Misses Q4 Earnings Estimates (zacks.com, 2026-09-08)
TickrTrends take: InnovAge's Q4 earnings miss represents a performance gap that valuation analysts will need to reconcile with the company's current market pricing, particularly as the Healthcare sector experiences varying growth pressures. With TickrTrends' verdict still awaiting full valuation, this earnings shortfall could influence how the company's fundamental metrics are ultimately assessed against comparable Healthcare operators. Investors monitoring INNV's valuation development should track whether management provides revised guidance and commentary on operational challenges that contributed to the miss.
What people are saying
Follow the INNV conversation: Stocktwits · Reddit · X
TickrTrends weekly updates
- 2026-09-07 — No material change this week: the verdict, bands and grades all held steady.
- 2026-09-06 — No material change this week: the verdict, bands and grades all held steady.
- 2026-08-31 — TickrTrends initiated weekly Forward Fair Value coverage of this stock.
Frequently asked questions
Is INNV stock undervalued?
INNV does not yet have sufficient validated earnings history for a full Forward Fair Value verdict under TickrTrends' standards; it is re-evaluated every week.
What is INNV's TickrTrends verdict?
INNV is currently marked 'Awaiting full valuation' - a verdict publishes automatically once at least six validated trailing P/E windows accumulate.
Is INNV overbought or oversold?
INNV's 14-day RSI is in neutral territory - neither overbought nor oversold.